Which pill do patients prefer? study compares two chemo options for colorectal cancer

NCT ID NCT00905047

Completed Symptom relief Sponsor: Centre Oscar Lambret Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at two oral chemotherapy drugs, Xeloda and UFT with folinic acid, in 89 people with advanced or metastatic colorectal cancer. The main goal was to see which treatment patients preferred after trying both. The study also checked how safe each drug was. Results help doctors understand patient preferences when choosing between these two treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colonic neoplasm colorectal cancer colorectal neoplasm Neoplasm Metastasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLORECTAL CANCER

Contacts and locations

Locations

Centre Hospitalier

Armentières, 59280, France
Centre Hospitalier

Roubaix, 59100, France
Centre Hospitalier

Valenciennes, 59300, France
Centre Hospitalier Regional

Lille, 59035, France
Centre Hospitalier de Béthune

Beuvry, 62660, France
Centre Hospitalier de CHOLET

Cholet, 49300, France
Centre Joliot-Curie

Saint Martin Les Boulogne, 62280, France
Centre Leonard de Vinci

Dechy, 59187, France
Centre Oscar Lambret

Lille, 59020, France
Centre Paul Papin

Angers, 49033, France
Clinique des Dentellieres

Valenciennes, 59300, France
Hopital Saint Vincent de Paul

Lille, 59020, France
Polyclinique du Bois

Lille, 59000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.